Value analysis has always occupied the intersection of clinical quality, operational efficiency, and financial stewardship. Those core responsibilities have not changed. The environment in which we carry them out has changed considerably.
Healthcare organizations now contend with larger volumes of data, a continually expanding body of literature, and mounting operational complexity, alongside rising expectations for both the speed and the defensibility of their decisions. Value analysis teams are still expected to evaluate products and technologies with full rigor, yet they must increasingly do so within timelines considerably shorter than those their predecessors worked against.
It is against this backdrop that artificial intelligence has entered the value analysis conversation. Much of that conversation, in my observation, has been conducted in extremes.
One camp presents the technology as an imminent replacement for professional expertise; another regards it chiefly as a source of risk. Having spent a number of years in value analysis, I find neither framing especially instructive. The more accurate account is also the less dramatic one. Artificial intelligence is best understood as a tool that helps experienced professionals manage complexity; it does not replace the judgment that complexity demands.
The nature of value analysis work makes this distinction consequential. A product evaluation is rarely reducible to a single variable. When a request reaches committee, we weigh clinical outcomes, utilization patterns, reimbursement implications, workflow effects, standardization opportunities, physician preference, and long-term cost simultaneously, and ordinarily on the basis of incomplete information.
Historically, that synthesis has been accomplished through manual review, spreadsheet analysis, committee deliberation, and the painstaking reconciliation of information drawn from disparate sources. Those methods remain sound. What has begun to strain is their sufficiency: the volume of relevant information now exceeds what any fully manual process was designed to absorb.
This does not diminish the importance of traditional analytical skill. The ability to scrutinize a financial model, appraise the quality of a study, and anticipate how a product will behave in a live clinical workflow remains indispensable. But there is a meaningful difference between organizing information and interpreting it at scale, and it is in that gap that artificial intelligence has a legitimate contribution to make.
Evidence synthesis offers perhaps the clearest illustration. A thorough review of the literature is both necessary and inherently time-consuming: it requires retrieving studies, comparing methodologies, identifying limitations, grading levels of evidence, and reconciling findings that frequently conflict. AI tools have begun to assist with discrete portions of that process, categorizing literature, summarizing recurring themes, and surfacing inconsistencies that warrant closer examination.
What these tools do not do is the interpretive work on which sound conclusions ultimately depend. Determining whether a study’s findings apply to a particular patient population, recognizing bias the authors did not acknowledge, and weighing evidence against an organization’s specific priorities all require professional training and contextual understanding. If anything, delegating the mechanical sorting of information to a machine makes the interpretive contribution of the professional more visible, not less. The technology can accelerate synthesis; accountability for the resulting decision remains with the professionals who lead it.
The operational implications deserve more attention than they ordinarily receive. One of the least visible costs in any healthcare organization is the time consumed by its own decision-making. Every week a product remains under review is a week in which an existing inefficiency persists, or a beneficial technology stays out of clinicians’ hands. Such delays carry an operational and financial price that seldom appears explicitly in any report. To the extent that AI can reduce the administrative friction in this work (largely the consolidation and reformatting of fragmented information), it allows value analysis professionals to devote a greater share of their time to what most requires their expertise: interpretation and judgment.
Equally consequential, and considerably less settled, is the question of governance. As AI tools become more accessible, professionals across many organizations have already begun to incorporate them into routine tasks such as drafting and summarizing. In a great many institutions, that adoption is outpacing the development of any formal structure to govern it. The gap is a real leadership challenge, and not one that can responsibly be deferred.
The central concern surrounding artificial intelligence is not, in most cases, whether the technology functions, since it frequently does so capably. The more demanding questions concern transparency, validation, oversight, and accountability. How will outputs be validated, and by whom? When an AI-assisted analysis informs a consequential decision, where does responsibility ultimately reside? These are not, at their core, technical questions. They are organizational and professional questions, and answering them well requires deliberate leadership.
Value analysis professionals are well positioned to contribute to that effort. Arguably, they are better positioned than most. Our discipline is already organized around evidence evaluation, multidisciplinary collaboration, financial stewardship, and balanced decision-making under conditions of uncertainty, which are precisely the competencies that responsible AI integration requires. In effect, the profession has been practicing the human dimension of this problem for years.
The appropriate posture, then, is neither uncritical adoption nor reflexive resistance; healthcare organizations are rarely well served by either. Sustainable progress tends to follow from structured evaluation, measured implementation, and sound governance. That is the disciplined approach the profession would bring to any significant new product or technology, and artificial intelligence should be held to precisely the same standard.
Organizations that integrate these tools thoughtfully into evidence review and operational analysis may well find themselves better equipped to manage rising complexity without sacrificing rigor or efficiency. Such integration, however, changes less than its more enthusiastic proponents suggest.
Technology does not substitute for leadership. It does not substitute for clinical judgment, for ethical oversight, or for a clear understanding of an organization’s particular context. If anything, the more widely AI is deployed across healthcare workflows, the greater the premium on experienced professionals who can evaluate its outputs critically, recognize their limitations, pose the questions the system itself will not, and keep institutional decisions aligned with patient care and organizational values.
Artificial intelligence can assist materially with analysis and synthesis. Responsibility cannot be delegated in the same way. It remains, as it always has, a human obligation.
Article by:
Kyle P. Atkins, Ed.S., NRP, FACHDM
Kyle is a healthcare leader, educator, and strategist focused on advancing the responsible use of artificial intelligence in healthcare value analysis. His work centers on applying AI within complex, human-centered systems — strengthening evidence synthesis, decision governance, and operational clarity without compromising ethics, trust, or clinical judgment. A contributor to the Association of Healthcare Value Analysis Professionals (AHVAP) Expert Position Statement on Artificial Intelligence, Kyle actively supports the development of ethical, explainable, and governed AI practices across value analysis programs. Readers interested in expanding their professional development and access to AI-focused resources, including the AHVAP AI Insight Hub, are encouraged to learn more about AHVAP membership at www.ahvap.org. Additional commentary and analysis on AI, governance, and value-based decision-making can be found at kyle.veritastech.io/blog.
Articles you may like:
Artificial Intelligence and Value Analysis: From Concept to Competence
